Despite disruptions to testing and risk behaviour during COVID-19, the latest data from UNSW Sydney’s Kirby Institute shows Australia is tracking well towards the elimination of HIV transmission.
The major gift will support prevention research for one of Australia’s most neglected cancers.
A new report finds most STIs in Australia remain undiagnosed and untreated, highlighting a need to increase STI testing across the country.
The Kirby Institute is calling for people at risk of monkeypox to enrol in the TraX study to help shape the public health response.
The sustained downward trend is likely due to high uptake of prevention measures, testing and high levels of treatment.
UNSW Sydney researchers have secured more than $6 million for five projects that will improve public health services.
Researchers have revealed the final results of the first study that measured the impact of PrEP on reducing HIV in a large population.
New HIV data, released today by the Kirby Institute at UNSW Sydney for World AIDS Day, are a reminder for Australia to sustain its efforts in HIV prevention amidst the COVID-19 pandemic.
A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.
NSW is on track to virtually eliminate HIV transmission by 2020 as an expanded PrEP trial, led by the Kirby Institute at UNSW, enrols its one thousandth participant in record time.